Delivery Order SPE2DB24D3014-SPE2DB25FKTPX
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price of $1,015.32 and a period of performance through May 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,126.86 and a period of performance through February 26, 2025. The contract is a firm-fixed-price, non-set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $1,352.64 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This $6,538.05 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on February 3, 2025. The contract provides for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product, with a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $2,132.82 and a completion date of June 16, 2025. The contract is a Firm Fixed Price contract and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567732632 BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a medical product, with a ceiling value of $1,959.66. The contract is a firm fixed price, delivery order type and runs through March 31, 2025. The award was made on March 28, 2025 and does not have a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $5,077.36 and a completion date of June 13, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.52, is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication, to support military healthcare programs. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of January 14, 2025. It is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for the pharmaceutical product "BUDESONIDE-FORMOTEROL 160-4.5 10.2GM" and has a firm fixed price ceiling value of $1,023.78. The contract was awarded on August 2, 2024, with an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed-price ceiling value of $2,486.88 and an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...